UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000017069
Receipt number R000019773
Scientific Title Randomized phase III study comparing erlotinib plus bevacizumab to erlotinib alone in patients with previously untreated non-small cell lung cancer harboring EGFR mutation (NEJ026)
Date of disclosure of the study information 2015/04/07
Last modified on 2018/08/09 21:04:36

No. Disposal Last modified on Item of update
1 Insert 2015/04/07 22:58:20
2 Update 2015/04/07 23:09:27 Acronym
Acronym
3 Update 2015/05/20 12:05:13 Recruitment status
4 Update 2016/09/05 11:09:33 Recruitment status
5 Update 2018/04/09 16:25:39 Results
Other related information
6 Update 2018/08/09 21:01:07 Organization
Organization
Division name
Division name
Address
Address
TEL
Name of primary person or sponsor
Organization
7 Update 2018/08/09 21:03:03 Publication of results
Other related information
8 Update 2018/08/09 21:04:36 Key inclusion criteria
Key inclusion criteria